HEMATOLOGICAL ONCOLOGY（血液肿瘤学杂志）影响因子_期刊投稿发表

期刊简介

Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders-Diagnostic investigations, including imaging and laboratory assays-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.

血液肿瘤学考虑发表文章处理实验和临床方面的肿瘤疾病的造血和淋巴系统和相关的问题。将基础科学应用于临床问题的转化研究尤其受欢迎。鼓励撰写涉及以下领域的手稿：-血液肿瘤的临床实践和管理，包括：急性和慢性白血病、恶性淋巴瘤、骨髓增生性疾病-诊断研究，包括成像和实验室分析-血液病的血液瘤形成的流行病学、病理学和病理生物学-治疗问题，包括I期、II期或III期试验以及同种异体和自体干细胞移植研究-细胞生物学、分子生物学、分子遗传学和细胞遗传学的正常或患病的造血和淋巴细胞生成，包括干细胞和细胞因子和其他调控系统。简洁，专题审查材料是受欢迎的，特别是如果它使新的概念和想法获得更广泛的社区。可与主编讨论有关审查材料的建议。仅当病例材料和病例报告具有更广泛的科学或临床相关性时，才会考虑收集这些材料和报告。

《HEMATOLOGICAL ONCOLOGY》期刊已被查看：次

分区信息